Presentation

0 Comments

18 December 2016

Antiplatelet therapy in patients with diabetes

Mark B Effron

Questions To Industry II: Antiplatelet therapy in patients with diabetes

Previous | Next
Download

Summary

Mark Effron describes the background of diabetes how it is a major health concern. He then describes the pathogenesis of platelet dysfunction in patients with diabetes. He then describes the data from the Principle-TIMI 44 and TRITON-TIMI 38 studies.

Download

Summary

Mark Effron describes the background of diabetes how it is a major health concern. He then describes the pathogenesis of platelet dysfunction in patients with diabetes. He then describes the data from the Principle-TIMI 44 and TRITON-TIMI 38 studies.

You have to be a BCIS member to access this content

Either Sign in or register to become a member, today! Join BCIS Sign In